Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

MM32: Diagnosis: SARS-CoV2 Antigen Testing

In this presentation, Dr. Jens Lundgren reviews tests for SARS-CoV-2 infection, with emphasis on assays that detect viral antigens.
Jens D. Lundgren, MD, DMSc
Released: January 29, 2021

Information on this Educational Activity

Faculty

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Copenhagen, Denmark
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Jens D. Lundgren, MD, DMSc, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

In this presentation, Dr. Sharon Lewin reviews investigational therapies for COVID-19: TMPRSS2 inhibitors, CRISPR-Cas13, and interferon lambda.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: March 18, 2021

Dr. Vikram Mukherjee reviews recent studies on thromboprophylaxis and anticoagulation in persons with COVID-19, from Clinical Care Options (CCO)

Vikramjit Mukherjee, MD Released: February 19, 2021

Dr. Arthur Kim reviews EUAs for baricitinib, bamlanivimab, and casirivimab/imdevimab, and NIH Guideline on ivermectin from Clinical Care Options (CCO)

Arthur Kim, MD Released: January 25, 2021

Dr. Roger Paredes reviews safety and efficacy data on COVID-19 vaccines and considerations for vaccine rollout from Clinical Care Options (CCO)

Roger Paredes, MD, PhD Released: January 7, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue